Institut De Recherches Internationales Servier

This study tested a drug called calaspargase pegol in adults aged 22 and older with a specific type of leukemia (Philadelphia-negative ALL). The goal was to find the right dose and check for side effects. The trial was stopped early, but researchers were looking at how the drug w…

This study used PET scans to track where a new antibody drug (S095012) goes in the body and in tumors of people with advanced solid cancers. Only 3 participants were enrolled before the study was stopped early. The goal was to understand how the drug spreads and targets tumors, n…